These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8879601)

  • 1. The efficacy of felodipine ER on regression of left ventricular hypertrophy in patients with primary hypertension.
    Nalbantgil I; Onder R; Killiçcioglu B; Boydak B; Terzioglu E; Yilmaz H
    Blood Press; 1996 Sep; 5(5):285-91. PubMed ID: 8879601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of irbesartan vs felodipine in the regression after 1 year of left ventricular hypertrophy in hypertensive patients (the SILVER trial). Study of Irbesartan in Left VEntricular hypertrophy Regression.
    Cohen A; Bregman B; Agabiti Rosei E; Williams B; Dubourg O; Clairefond P; Brudi P; Gosse P; Guéret P
    J Hum Hypertens; 1998 Jul; 12(7):479-83. PubMed ID: 9702935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of felodipine and nifedipine on 24-h blood pressure and left ventricular mass.
    Myers MG; Leenen FH; Tanner J
    Am J Hypertens; 1995 Jul; 8(7):712-8. PubMed ID: 7546497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rest and effort hemodynamic responses during prolonged treatment with felodipine, 24-h blood pressure monitoring, and echocardiographic changes.
    Zimlichman R; Schwartz J; Tobar R
    Am J Hypertens; 1997 Aug; 10(8):905-12. PubMed ID: 9270086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of once-daily antihypertensive drugs on blood pressure, left ventricular mass and sympathetic activity: Nifedipine-GITS versus felodipine-ER versus enalapril.
    Leenen FH; Myers MG; Joyner CD; Toal CB
    Can J Cardiol; 2002 Dec; 18(12):1285-93. PubMed ID: 12518180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regression of left ventricular hypertrophy in hypertensive patients after 1 year of treatment with rilmenidine: a double-blind, randomized, controlled (versus nifedipine) study.
    Sadowski Z; Szwed H; Kuch-Wocial A; Kubasik A; Januszewicz W; Krupa-Wojciechowska B; Polak G; Stejfa M; Dvorak I; Balazovjech I; Dubai G; Simon K
    J Hypertens Suppl; 1998 Aug; 16(3):S55-62. PubMed ID: 9747912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smooth blood pressure control obtained with extended-release felodipine in elderly patients with hypertension: evaluation by 24-hour ambulatory blood pressure monitoring.
    Antonicelli R; Omboni S; Giovanni DC; Ansuini R; Mori A; Gesuita R; Parati G; Paciaroni E
    Drugs Aging; 2002; 19(7):541-51. PubMed ID: 12182690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low dosages of felodipine ER once daily as monotherapy in elderly hypertensive patients: effect on ambulatory blood pressure and quality of life.
    van Ree JW; van der Pol GA
    J Hum Hypertens; 1996 Sep; 10(9):613-8. PubMed ID: 8953207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-year study of felodipine or placebo for stage 1 isolated systolic hypertension.
    Black HR; Elliott WJ; Weber MA; Frishman WH; Strom JA; Liebson PR; Hwang CT; Ruff DA; Montoro R; DeQuattro V; Zhang D; Schleman MM; Klibaner MI
    Hypertension; 2001 Nov; 38(5):1118-23. PubMed ID: 11711508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Office and ambulatory blood pressure: a comparison between amlodipine and felodipine ER. Danish Multicentre Group.
    Høegholm A; Wiinberg N; Rasmussen E; Nielsen PE
    J Hum Hypertens; 1995 Aug; 9(8):611-6. PubMed ID: 8523374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term efficacy, tolerability, and safety of the combination of enalapril and felodipine ER in the treatment of hypertension. Enalapril-Felodipine ER Factorial Study Group.
    Gradman AH; Cutler NR; Davis PJ; Robbins JA; Weiss RJ; Wood BC; Michelson EL
    Clin Ther; 1998; 20(3):527-38. PubMed ID: 9663368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twenty-four-hour antihypertensive efficacy of felodipine 10 mg extended-release: the Italian inter-university study.
    Pannarale G; Puddu PE; Monti F; Irace L; Bentivoglio M; Collauto F; Barsotti A; Corea L; Trevi G; Campa PP; Jacono A
    J Cardiovasc Pharmacol; 1996 Feb; 27(2):255-61. PubMed ID: 8720425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of clinical efficacy and adverse effects between extended-release felodipine and atenolol in patients with mild and moderate essential hypertension.
    Chern MS; Lin FC; Wu D
    Changgeng Yi Xue Za Zhi; 1997 Jun; 20(2):86-93. PubMed ID: 9260367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dose-finding, placebo-controlled study on extended-release felodipine once daily in treatment of hypertension.
    Cambell LM; Ross JR; Goves JR; Lees CT; McCullagh A; Barnes P; Timerick SJ; Richardson PD
    J Cardiovasc Pharmacol; 1989 Dec; 14(6):869-73. PubMed ID: 2481775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
    Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y
    Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT).
    Frishman WH; Hainer JW; Sugg J;
    Am J Hypertens; 2006 Apr; 19(4):388-95. PubMed ID: 16580575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of left ventricular hypertrophy during long-term antihypertensive treatment--a comparison between felodipine and the combination of felodipine and metoprolol.
    Wetzchewald D; Klaus D; Garanin G; Lohr E; Hoffmann J
    J Intern Med; 1992 Mar; 231(3):303-8. PubMed ID: 1532616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised, double-blind, parallel study of the anti-hypertensive efficacy and safety of losartan potassium compared with felodipine ER in elderly patients with mild to moderate hypertension.
    Chan JC; Critchley JA; Lappe JT; Raskin SJ; Snavely D; Goldberg AI; Sweet CS
    J Hum Hypertens; 1995 Sep; 9(9):765-71. PubMed ID: 8551492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure reduction and tolerability of felodipine ER in older and younger hypertensive patients. The Felodipine ER in the Elderly versus Young Working Group.
    Fagan TC
    J Am Geriatr Soc; 1997 Jun; 45(6):712-7. PubMed ID: 9180665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of clinical efficacy and adverse effects between extended-release felodipine and slow-release diltiazem in patients with isolated systolic hypertension.
    Chern MS; Lin FC; Wu D
    Changgeng Yi Xue Za Zhi; 1999 Mar; 22(1):44-51. PubMed ID: 10418209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.